ReNeuron
Company focused on the research, development, and commercial exploitation of stem cell technologies
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug treatments.
Visit website: http://www.reneuron.com/
Details last updated 03-Oct-2019
ReNeuron News
Advances in stem cell cures by new biotech startups
GEN News - 03-Nov-2020
New generation companies develop novel cell therapies using stem cells
Read more...